Cargando…

Financing and collaboration on research and development for nodding syndrome

BACKGROUND: Nodding syndrome is a neurological disease with no known cure or treatment, impacting children aged 3–18 years old, mainly in East Africa. Children progressively develop varying degrees of cognitive impairment which may lead to severe wasting, a vegetative state and, eventually, death. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Årdal, Christine, Røttingen, John-Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794815/
https://www.ncbi.nlm.nih.gov/pubmed/26983551
http://dx.doi.org/10.1186/s12961-016-0091-6
_version_ 1782421526541238272
author Årdal, Christine
Røttingen, John-Arne
author_facet Årdal, Christine
Røttingen, John-Arne
author_sort Årdal, Christine
collection PubMed
description BACKGROUND: Nodding syndrome is a neurological disease with no known cure or treatment, impacting children aged 3–18 years old, mainly in East Africa. Children progressively develop varying degrees of cognitive impairment which may lead to severe wasting, a vegetative state and, eventually, death. Despite its 50-year existence, little is known about its cause, risk factors and prognosis. It is a disease where markets will not provide solutions because the patients are both too few and too poor, making it especially neglected. Open source innovation has been recommended as an approach to neglected disease research in order to maximize available funding through greater collaboration and openness to results. Nodding syndrome is a useful case to examine the relevance of open source innovation. METHODS: We assessed the magnitude of research related to nodding syndrome, its availability, financing and the amount of collaboration. We surveyed researchers regarding their motivations, attitudes toward open source innovation concepts and barriers to greater collaboration. RESULTS: Little research is occurring for nodding syndrome, but it is openly available and researchers are highly collaborative. The disease is largely unknown, which is partly attributed to WHO not classifying nodding syndrome as a neglected tropical disease and not including it in any formal programme. Impacted countries, particularly Uganda, demonstrate a strong degree of ownership through both authorship and research financing. Nodding syndrome researchers have been allocated a total of €5 million from 2013 to 2019 in grant funding. Annual financing, due to three new grants, doubled from 2014 to 2015. CONCLUSIONS: Nodding syndrome, a disease previously ignored by the international community, is starting to receive greater attention, although financing remains modest. If infectious, a larger epidemic could take the world by surprise. Open source innovation can likely help by sharing research protocols (to avoid duplication) and early research results (to adjust to the findings of others). The existing scientists have already endorsed open source innovation, but increased financing is needed. The support of just a few high-income countries could reap a large impact.
format Online
Article
Text
id pubmed-4794815
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47948152016-03-17 Financing and collaboration on research and development for nodding syndrome Årdal, Christine Røttingen, John-Arne Health Res Policy Syst Research BACKGROUND: Nodding syndrome is a neurological disease with no known cure or treatment, impacting children aged 3–18 years old, mainly in East Africa. Children progressively develop varying degrees of cognitive impairment which may lead to severe wasting, a vegetative state and, eventually, death. Despite its 50-year existence, little is known about its cause, risk factors and prognosis. It is a disease where markets will not provide solutions because the patients are both too few and too poor, making it especially neglected. Open source innovation has been recommended as an approach to neglected disease research in order to maximize available funding through greater collaboration and openness to results. Nodding syndrome is a useful case to examine the relevance of open source innovation. METHODS: We assessed the magnitude of research related to nodding syndrome, its availability, financing and the amount of collaboration. We surveyed researchers regarding their motivations, attitudes toward open source innovation concepts and barriers to greater collaboration. RESULTS: Little research is occurring for nodding syndrome, but it is openly available and researchers are highly collaborative. The disease is largely unknown, which is partly attributed to WHO not classifying nodding syndrome as a neglected tropical disease and not including it in any formal programme. Impacted countries, particularly Uganda, demonstrate a strong degree of ownership through both authorship and research financing. Nodding syndrome researchers have been allocated a total of €5 million from 2013 to 2019 in grant funding. Annual financing, due to three new grants, doubled from 2014 to 2015. CONCLUSIONS: Nodding syndrome, a disease previously ignored by the international community, is starting to receive greater attention, although financing remains modest. If infectious, a larger epidemic could take the world by surprise. Open source innovation can likely help by sharing research protocols (to avoid duplication) and early research results (to adjust to the findings of others). The existing scientists have already endorsed open source innovation, but increased financing is needed. The support of just a few high-income countries could reap a large impact. BioMed Central 2016-03-17 /pmc/articles/PMC4794815/ /pubmed/26983551 http://dx.doi.org/10.1186/s12961-016-0091-6 Text en © Årdal and Røttingen. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Årdal, Christine
Røttingen, John-Arne
Financing and collaboration on research and development for nodding syndrome
title Financing and collaboration on research and development for nodding syndrome
title_full Financing and collaboration on research and development for nodding syndrome
title_fullStr Financing and collaboration on research and development for nodding syndrome
title_full_unstemmed Financing and collaboration on research and development for nodding syndrome
title_short Financing and collaboration on research and development for nodding syndrome
title_sort financing and collaboration on research and development for nodding syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794815/
https://www.ncbi.nlm.nih.gov/pubmed/26983551
http://dx.doi.org/10.1186/s12961-016-0091-6
work_keys_str_mv AT ardalchristine financingandcollaborationonresearchanddevelopmentfornoddingsyndrome
AT røttingenjohnarne financingandcollaborationonresearchanddevelopmentfornoddingsyndrome